4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-054101
Chairman and CEO bought 3,250 shares at an average $0.94 ($3,040)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Niihara Yutaka Chairman and CEO | 2020-10-05 | Purchase | +1,250 | $0.96 | $1,200 | 10,699,746 | D |
| Niihara Yutaka Chairman and CEO | 2020-10-06 | Purchase | +2,000 | $0.92 | $1,840 | 10,701,746 | D |
| Open-market purchases · 3,250 sh · avg $0.94 · $3,040 | |||||||
Loading xslF345X03/doc4.xml…